Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2006;99:1285-1286
doi: 10.1161/01.RES.0000253141.65450.fc
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by De Mello, W. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by De Mello, W. C.
Related Collections
Right arrowRelated Article
(Circulation Research. 2006;99:1285.)
© 2006 American Heart Association, Inc.


Editorials

On the Pathophysiological Implications of an Intracellular Renin Receptor

Walmor C. De Mello

From the School of Medicine, Medical Sciences Campus, University of Puerto Rico, San Juan.

Correspondence to Walmor C. De Mello, Medical Sciences Campus, School of Medicine, PO Box 36–5067, San Juan, PR 00936-5067, USA. E-mail wmello@rcm.upr.edu



See related article, pages 1355–1366


Key Words: intracellular • renin • receptor • patophysiological • implications


An extract of the first 250 words of the full text is provided, because this article has no abstract.
 

The renin angiotensin system plays an important role on the regulation of arterial pressure, blood volume and cardiac function. Both a circulating and several tissue-localized systems have been identified and able to cleave angiotensinogen by renin to form angiotensin I which is converted to angiotensin II (Ang II) by angiotensin converting enzyme. The presence of local Ang II generation, which has been supported by the beneficial effects of Ang II AT1 receptor blockers and ACE inhibitors independently of their effects on arterial blood pressure, certainly requires that renin, angiotensinogen and ACE be synthesized locally or taken from the plasma.

Concerning the presence of the different components of the RAS in different tissues1 evidence is available that in nephrectomized rats, the renin levels in the heart, for instance, are extremely low2 what indicates that intracellular renin in cardiac myocytes of normal animals, would need to come from plasma. However, rats transgenic for the mouse ren-2d renin gene develop severe hypertension and cardiac remodeling3 and incubation of cardiac myocytes from these animals with prorenin (the precursor of renin) leads to intracellular appearance of angiotensin I and II3 what suggests prorenin internalization. Moreover, an alternative transcript for a nonsecreted renin has been described in brain and heart.4,5 The transfection of a nonsecreted form of angiotensinogen into hepatoma cells that expressed this renin transcript, increased proliferation by a process that is sensitive to renin antisense,6 indicating that the renin transcript has functional properties. Indeed, the alternative renin trancript is upregulated in adult rats with . . . [Full Text of this Article]


Related Article:

A Novel Signal Transduction Cascade Involving Direct Physical Interaction of the Renin/Prorenin Receptor With the Transcription Factor Promyelocytic Zinc Finger Protein
Jan H. Schefe, Mario Menk, Jana Reinemund, Karin Effertz, Robin M. Hobbs, Pier Paolo Pandolfi, Patricia Ruiz, Thomas Unger, and Heiko Funke-Kaiser
Circ. Res. 2006 99: 1355-1366. [Abstract] [Full Text] [PDF]



This article has been cited by other articles:


Home page
HypertensionHome page
E. D. Frohlich
The Salt Conundrum: A Hypothesis
Hypertension, July 1, 2007; 50(1): 161 - 166.
[Full Text] [PDF]